Skip to main content
. 2020 Apr 8;10(10):1866–1879. doi: 10.1016/j.apsb.2020.03.004

Table 1.

Compounds or drugs targeting mitochondrial quality control (MQC) in cardiac I/R injury.

Name Target Ref.
Mdivi-1 Mitochondrial fission (DRP1) 179,180
Propofol Mitochondrial fission (DRP1) 181
Dapagliflozin Mitochondrial fission (DRP1) 182
Dynasore Mitochondrial fission (DRP1) 183
Isosteviol sodium Mitochondrial fission (DRP1/FIS1) 184
Tetrahydrocurcumin Mitochondrial fission and fusion (DRP1 and MFN2) 185
Pravastatin Mitochondrial fission and fusion (DRP1 and MFN1) 186
Vildagliptin Mitochondrial fusion (MFN2) 64
Mitochondrial fusion promoter M1 Mitochondrial fusion (MFN1/2 and OPA1) 187
Melatonin Mitochondrial fusion and mitophagy (OPA1 and FUNDC1) 79 , 122
Tongxinluo Mitophagy (PARKIN) 188
Bicarbonate Mitophagy (PARKIN) 189
Simvastatin Mitophagy (PARKIN) 190
Ellagic acid Mitophagy (BNIP3) 117
Hydrogen-rich saline Mitophagy (PARKIN) 191
Metformin Necroptosis (RIPK1 and RIPK3) 192
Dexmedetomidine Necroptosis (RIPK3) 193
Necrostatin-1 Necroptosis (RIPK1) 194
Baicalin Necroptosis (RIPK3 and MLKL) 195
Ciclosporin A Necroptosis (mPTP opening) 167
Tanshinone IIA Apoptosis (BAX/BCL2) 196
Taxifolin Apoptosis (BAX/BCL2) 197
Glutamine Apoptosis (Cyt-c) 198
Febuxostat Apoptosis (Cyt-c) 199
PD150606 Apoptosis (Cyt-c) 42
Ru360 Apoptosis (BAX) 200